相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys
Scott J. Webster et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
Jun Wang et al.
MOLECULAR NEURODEGENERATION (2011)
Dimebon Does Not Ameliorate Pathological Changes Caused by Expression of Truncated (1-120) Human Alpha-Synuclein in Dopaminergic Neurons of Transgenic Mice
Tatyana A. Shelkovnikova et al.
NEURODEGENERATIVE DISEASES (2011)
Dimebon Inhibits Calcium-Induced Swelling of Rat Brain Mitochondria But Does Not Alter Calcium Retention or Cytochrome C Release
Kranthi Kumari Naga et al.
NEUROMOLECULAR MEDICINE (2011)
Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions
Trevor Archer et al.
NEUROTOXICITY RESEARCH (2011)
Astrocyte-neuron metabolic relationships: for better and for worse
Igor Allaman et al.
TRENDS IN NEUROSCIENCES (2011)
A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease
Karl Kieburtz et al.
ARCHIVES OF NEUROLOGY (2010)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Discovery of a Proneurogenic, Neuroprotective Chemical
Andrew A. Pieper et al.
CELL (2010)
From Anti-allergic to Anti-Alzheimer's: Molecular Pharmacology of Dimebon™
I. Okun et al.
CURRENT ALZHEIMER RESEARCH (2010)
Dimebon (Latrepirdine) Enhances Mitochondrial Function and Protects Neuronal Cells from Death
Shouting Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism
Marco Giorgetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models
Makiko Yamashita et al.
FEBS LETTERS (2009)
Intrinsic disorder in proteins associated with neurodegenerative diseases
Vladimir N. Uversky
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
γ-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein
Natalia Ninkina et al.
HUMAN MOLECULAR GENETICS (2009)
Liquid chromatography-tandem mass spectrometry method for the quantification of dimebon in rat plasma and brain tissue
Ramakrishna Nirogi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo
John W. Steele et al.
MOLECULAR NEURODEGENERATION (2009)
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
Rachelle S. Doody et al.
LANCET (2008)
Evaluation of Dimebon in cellular model of Huntington's disease
Jun Wu et al.
MOLECULAR NEURODEGENERATION (2008)
Autoantibodies to alpha-synuclein in inherited Parkinson's disease
Katerina K. Papachroni et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Astrocytes are active players in cerebral innate immunity
Cinthia Farina et al.
TRENDS IN IMMUNOLOGY (2007)
The roles of intracellular protein-degradation pathways in neurodegeneration
David C. Rubinsztein
NATURE (2006)
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
CF Orr et al.
BRAIN (2005)
Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ-synuclein, α-synuclein and double α/γ-synuclein null mutant mice
DC Robertson et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons
VV Grigor'ev et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene
N Ninkina et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Organization of the mouse Ruk locus and expression of isoforms in mouse tissues
VL Buchman et al.
GENE (2002)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
M Bucciantini et al.
NATURE (2002)
H1-antihistamines:: inverse agonism, anti-inflammatory actions and cardiac effects
R Leurs et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
